欧洲心脏安全服务市场玩家,规模,报告,价值,预测趋势到2029年

欧洲心脏安全服务市场，按服务（ECG/Holter 测量、血压测量、体外心脏安全评估服务、心血管成像、实时遥测监测、ECGS 中央过度读取、无创心脏成像、生理压力测试、全面 QT 研究、TQT 和暴露反应模型、血小板聚集和其他服务）、阶段（第 1 阶段、第 2 阶段和第 3 阶段）、类型（综合服务和独立服务）、最终用户（制药和生物制药公司、合同研究组织和学术及研究机构）划分的行业趋势和预测到 2029 年。

市场分析和见解

欧洲心脏安全服务市场受到临床试验数量增加,主要市场参与者越来越多以及技术创新等因素的驱动,这些因素增强了其需求,并增加了研发投资,导致市场增长. 目前,正在进行各种研究,预计这将为制造商开发新的和创新的心脏安全服务系统创造竞争优势,预计将为心脏安全服务市场提供各种其他机会。然而,政府严格的批准条例预计会阻碍增长。

Cardiac Safety Services Market

欧洲心脏安全服务市场报告详细介绍了市场份额、新发展和产品管道分析、国内和地方市场参与者的影响、分析新兴收入领域的机会、市场监管的变化、产品批准、战略决策、产品发布、地域扩张以及市场技术创新。为了了解分析和市场状况联系我们做一个分析员简报我们的团队将帮助你创造收入影响解决方案实现你期望的目标各区域发展中国家零售单位的可扩展性和商业扩展,以及同供应商结成安全销售机器和药物产品的伙伴关系,是推动预测期间市场需求的主要因素。

欧洲心脏安全服务市场是支持性的,旨在减少疾病的发展。数据桥市场研究分析认为,欧洲心脏安全服务市场将在2022至2029年的预测期间以14.8%的CAGR增长.

报表计量	细节
预测期	2022至2029年统计
基准年	2021
历史年代	2020年(2019-2014年可定制).
数量单位	收入(百万美元),定价(美元)
覆盖部分	按服务单位分列(ECG/Holter计量、血压测量在维特罗心脏病安全评估服务、心血管成像、实时遥测监测、ECGS中心超读、非侵入性心血管成像、生理应激测试、彻底QT研究、TQT和接触反应模型、板块聚合和其他服务)、阶段(第一阶段、第二阶段和第三阶段)、类型(综合服务和独立服务)、终端用户(药品生物制药公司、合同研究组织和学术研究所)
涵盖国家	德国、法国、联合王国、意大利、西班牙、土耳其、俄罗斯、荷兰、瑞士、比利时和欧洲其他地区
覆盖的市场玩家	Koninklijke Philips N.V.,美国控股实验室公司、IQVIA、Medpace、Ncardia、Certara、Eurofins Science、SGS SA、Banook和Celerion等

市场定义:

心脏安全服务一般有助于支持和设计临床试验以及监测心脏安全所需的其他研究. 发达国家和发展中国家对心脏安全服务市场的需求都有所增加,其背后的原因是临床试验和产品推出的数量不断增加。由于引进了创新产品,技术产品增加,可支配收入增加,心脏安全服务市场正在增长. 由于对新兴市场的探索、市场参与者的战略举措、增加保健支出,预计的市场将增长。

欧洲心脏安全服务市场动态

司机

临床试验数量增加

临床试验是一种结构完善的系统,可追溯到几百年,仍然是药品审批所需的监管要求的支柱. 最近,临床试验领域取得了很大进展,增加了临床试验的数量,预计将推动市场增长。

临床试验的规范发生了各种变化,增加了临床试验的数量并取得了积极的成果 --

比如说,

根据"医学新闻"的文章,由于临床试验质量的提高,如对全体工作人员的强制培训,试验数量明显增加. 此外,2017年,NIH表示,所有调查人员和工作人员都应在NIH资助的试验中接受良好临床实践(GCP)培训.

增加保健支出和资金

一个国家在保健方面使用的资金和一段时间以来的增长率是多种多样的经济和社会因素所左右的,包括保健系统的筹资安排和结构。

随着人民可支配收入的增长,发达国家和新兴经济体的保健支出已经增加。用于保健的资金越多;一个国家的人口就越健康。

机会

新毒品开发的增加

临床试验对于发现和开发用于疾病治疗的新药物至关重要。这是研究者找出什么治疗方法在人身上有效或不起作用的最佳方法. 药物的开发被定性为形成治疗癌症、内分泌、代谢等各种疾病的药物或装置。

因此,临床试验是确保治疗药物在市场投放和人类消费前的安全和功效的最有效方法,其中包括心脏安全评价,这是任何医疗产品进入市场之前的一个基本部分。

限制/挑战

正确评估和报告临床心脏安全数据至关重要。任何医疗产品的批准和产品召回取决于心脏安全评价. 因此,有必要根据法律程序提供和进行心脏安全评价,否则会导致产品延迟批准,从而预期会限制市场增长。

比如说,

根据IQVIA的文章,在1957至2007年间,有47起药物上市后退出的情况,其中45%是由于对心血管毒性的关切。同样,在过去20年临床前阶段失败的潜在新药物分子中,有27%是由于心血管毒性所致,因为这些药物不符合规定的管制规定。

欧洲心脏安全服务市场分割

欧洲心脏安全服务市场分为类型、服务、相位和最终用户。各部门之间的增长有助于你分析特殊的增长领域和接近市场的战略,并确定你的核心应用领域和目标市场的差异。

服务

ECG/室内测量
血压测量
体外心脏安全评估服务
心血管成像
实时遥测监测
中央超读ECGS
非侵入性心脏成像
生理压力测试
彻底的QT 研究
TQT和接触反应模型
盘点汇总
其他服务

在服务的基础上,将心脏安全服务市场分成两个部分:欧共体政府/Holter测量、血压测量、体外心脏安全评估服务,心血管成像、实时遥测监测、ECGS中心超读、非侵入性心脏成像、生理应激测试、彻底的QT研究、TQT和暴露反应模型、板块聚合和其他服务

阶段

第1阶段
第2阶段
第3阶段

按阶段划分,将心脏安全服务市场分入第一阶段,第二阶段和第三阶段.

类型

综合服务
独立服务

根据类型,将心脏安全服务市场分入综合服务和独立服务.

结束用户

制药和生药公司
合同研究组织
学术和研究所

Cardiac Safety Services Market

在最终用户的基础上,心脏安全服务市场是分块药品和生药公司、合同研究组织以及学术和研究机构。

心脏安全处区域分析/见解

对心脏安全服务进行了分析,并按上述类型、服务、阶段和最终用户提供了市场规模的见解和趋势。

心脏安全服务报告涵盖的国家有德国、法国、英国、意大利、西班牙、土耳其、俄罗斯、荷兰、瑞士、比利时和欧洲其他地区。

由于新的药物开发和保健支出增加,预计德国将占主导地位。

报告的国家部分还提供了影响市场的因素和影响市场当前和未来趋势的市场监管变化。下游和上游价值链分析,技术趋势和搬运工的五种力分析等数据点,案例研究是用来预测个别国家市场情景的一些指针. 此外,还考虑了欧洲品牌的存在和可得性,以及它们由于来自当地和国内品牌的大规模或稀缺竞争而面临的挑战、国内关税和贸易路线的影响,同时对国家数据进行预测分析。

竞争性景观和心脏安全处分析

欧洲心脏安全服务市场竞争环境提供了竞争者的详细信息。详细情况包括公司概况、公司财务、创收、市场潜力、研发投资、新市场举措、欧洲存在、生产地点和设施、生产能力、公司优缺点、产品推出、产品宽度和广度以及应用优势。上述数据点仅与公司对心脏安全服务市场的重视有关。

市场上的一些主要角色有:Koninklijke Philips N.V.,美国控股实验室公司,IQVIA,Medpace,Ncardia,Certara,Eurofins Science,SGS SA, Banook,和Celerion等.

研究方法

数据收集和基准年分析使用具有大样本规模的数据收集模块。利用市场统计和连贯一致的模式分析和估计市场数据。此外,市场份额分析和主要趋势分析是市场报告的主要成功因素. DBMR研究小组采用的关键研究方法是数据三角化,涉及数据挖掘、数据变量对市场的影响分析以及初级(工业专家)验证。除此之外,数据模型包括供应商定位网格,市场时间线分析,市场概况和指南,公司定位网格,公司市场份额分析,计量标准,欧洲Vs区域和供应商份额分析. 如有进一步调查,请联系分析师。

SKU-68239

在线获取全球首个市场情报云平台的报告访问权限

点击图片放大

交互式数据分析仪表板
用于发现高增长潜力机会的公司分析仪表板
研究分析师支持（定制与咨询）
带有交互式仪表板的竞争对手分析
最新新闻、更新与趋势分析
利用基准分析的强大功能，实现全面的竞争对手跟踪

申请演示

表格列表

TABLE 1 PROPORTION OF WOMEN IN CLINICAL STUDIES, ACCORDING TO DEVELOPMENT PHASE

TABLE 2 PROBABILITY OF SUCCESS BY CLINICAL TRIAL PHASE TO THERAPEUTIC AREA

TABLE 3 MORTALITY RATES FROM CLINICAL TRIALS AND EUROPEAN SAFETY AND EXPOSURE SURVEY (ESES), DEATHS PER 100 (PYE)

TABLE 4 ADHERENCE RATE TO COMMON CARDIOVASCULAR MEDICATION

TABLE 5 PROPORTION OF WOMEN IN CLINICAL STUDIES, ACCORDING TO DEVELOPMENT PHASE

TABLE 6 INITIATIVES TO INCREASE ENROLLMENT IN CLINICAL TRIALS AMONG UNDERREPRESENTED POPULATIONS

TABLE 7 ESTIMATED COST OF CARDIAC SAFETY EVALUATION DEVICES

TABLE 8 EUROPE CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 9 EUROPE ECG/HOLTER MEASUREMENTS IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 EUROPE BLOOD PRESSURE MEASUREMENTS IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 EUROPE IN VITRO CARDIAC SAFETY ASSESSMENT SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 EUROPE IN VITRO CARDIAC SAFETY ASSESSMENT SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 13 EUROPE HUMAN IPSC-DERIVED CARDIOMYOCYTES MEA ASSAYS IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 14 EUROPE COMPREHENSIVE IN VITRO PROARRHYTHMIA ASSAY (CIPA) IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 15 EUROPE CARDIOVASCULAR IMAGING IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 EUROPE REAL TIME TELEMETRY MONITORING IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 EUROPE CENTRAL OVER-READ OF ECGS IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 EUROPE NON-INVASIVE CARDIAC IMAGING IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 EUROPE PHYSIOLOGIC STRESS TESTING IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 EUROPE THOROUGH QT STUDIES IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 EUROPE TQT AND EXPOSURE RESPONSE MODELLING IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 EUROPE PLATELET AGGREGATION IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 EUROPE OTHERS IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 EUROPE CARDIAC SAFETY SERVICES MARKET, BY PHASE, 2020-2029 (USD MILLION)

TABLE 25 EUROPE PHASE I IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 EUROPE PHASE II IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 EUROPE PHASE III IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 EUROPE CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 29 EUROPE INTEGRATED SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 EUROPE STANDALONE SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 EUROPE CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 32 EUROPE PHARMACEUTICALS & BIOPHARMACEUTICALS COMPANIES IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 EUROPE ACADEMIC AND RESEARCH INSTITUTE IN CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 EUROPE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 36 EUROPE CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 37 EUROPE IN VITRO CARDIAC SAFETY ASSESSMENT SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 38 EUROPE HUMAN IPSC-DERIVED CARDIOMYOCYTES MEA ASSAYS IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 39 EUROPE COMPREHENSIVE IN VITRO PROARRHYTHMIA ASSAY (CIPA) IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 40 EUROPE CARDIAC SAFETY SERVICES MARKET, BY PHASE, 2020-2029 (USD MILLION)

TABLE 41 EUROPE CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 42 EUROPE CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 43 GERMANY CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 44 GERMANY IN VITRO CARDIAC SAFETY ASSESSMENT SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 45 GERMANY HUMAN IPSC-DERIVED CARDIOMYOCYTES MEA ASSAYS IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 46 GERMANY COMPREHENSIVE IN VITRO PROARRHYTHMIA ASSAY (CIPA) IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 47 GERMANY CARDIAC SAFETY SERVICES MARKET, BY PHASE, 2020-2029 (USD MILLION)

TABLE 48 GERMANY CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 49 GERMANY CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 50 FRANCE CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 51 FRANCE IN VITRO CARDIAC SAFETY ASSESSMENT SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 52 FRANCE HUMAN IPSC-DERIVED CARDIOMYOCYTES MEA ASSAYS IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 53 FRANCE COMPREHENSIVE IN VITRO PROARRHYTHMIA ASSAY (CIPA) IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 54 FRANCE CARDIAC SAFETY SERVICES MARKET, BY PHASE, 2020-2029 (USD MILLION)

TABLE 55 FRANCE CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 56 FRANCE CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 57 U.K. CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 58 U.K. IN VITRO CARDIAC SAFETY ASSESSMENT SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 59 U.K. HUMAN IPSC-DERIVED CARDIOMYOCYTES MEA ASSAYS IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 60 U.K. COMPREHENSIVE IN VITRO PROARRHYTHMIA ASSAY (CIPA) IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 61 U.K. CARDIAC SAFETY SERVICES MARKET, BY PHASE, 2020-2029 (USD MILLION)

TABLE 62 U.K. CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 63 U.K. CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 64 ITALY CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 65 ITALY IN VITRO CARDIAC SAFETY ASSESSMENT SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 66 ITALY HUMAN IPSC-DERIVED CARDIOMYOCYTES MEA ASSAYS IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 67 ITALY COMPREHENSIVE IN VITRO PROARRHYTHMIA ASSAY (CIPA) IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 68 ITALY CARDIAC SAFETY SERVICES MARKET, BY PHASE, 2020-2029 (USD MILLION)

TABLE 69 ITALY CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 70 ITALY CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 71 SPAIN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 72 SPAIN IN VITRO CARDIAC SAFETY ASSESSMENT SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 73 SPAIN HUMAN IPSC-DERIVED CARDIOMYOCYTES MEA ASSAYS IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 74 SPAIN COMPREHENSIVE IN VITRO PROARRHYTHMIA ASSAY (CIPA) IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 75 SPAIN CARDIAC SAFETY SERVICES MARKET, BY PHASE, 2020-2029 (USD MILLION)

TABLE 76 SPAIN CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 77 SPAIN CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 78 TURKEY CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 79 TURKEY IN VITRO CARDIAC SAFETY ASSESSMENT SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 80 TURKEY HUMAN IPSC-DERIVED CARDIOMYOCYTES MEA ASSAYS IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 81 TURKEY COMPREHENSIVE IN VITRO PROARRHYTHMIA ASSAY (CIPA) IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 82 TURKEY CARDIAC SAFETY SERVICES MARKET, BY PHASE, 2020-2029 (USD MILLION)

TABLE 83 TURKEY CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 84 TURKEY CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 85 RUSSIA CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 86 RUSSIA IN VITRO CARDIAC SAFETY ASSESSMENT SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 87 RUSSIA HUMAN IPSC-DERIVED CARDIOMYOCYTES MEA ASSAYS IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 88 RUSSIA COMPREHENSIVE IN VITRO PROARRHYTHMIA ASSAY (CIPA) IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 89 RUSSIA CARDIAC SAFETY SERVICES MARKET, BY PHASE, 2020-2029 (USD MILLION)

TABLE 90 RUSSIA CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 91 RUSSIA CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 92 NETHERLANDS CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 93 NETHERLANDS IN VITRO CARDIAC SAFETY ASSESSMENT SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 94 NETHERLANDS HUMAN IPSC-DERIVED CARDIOMYOCYTES MEA ASSAYS IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 95 NETHERLANDS COMPREHENSIVE IN VITRO PROARRHYTHMIA ASSAY (CIPA) IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 96 NETHERLANDS CARDIAC SAFETY SERVICES MARKET, BY PHASE, 2020-2029 (USD MILLION)

TABLE 97 NETHERLANDS CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 98 NETHERLANDS CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 99 SWITZERLAND CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 100 SWITZERLAND IN VITRO CARDIAC SAFETY ASSESSMENT SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 101 SWITZERLAND HUMAN IPSC-DERIVED CARDIOMYOCYTES MEA ASSAYS IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 102 SWITZERLAND COMPREHENSIVE IN VITRO PROARRHYTHMIA ASSAY (CIPA) IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 103 SWITZERLAND CARDIAC SAFETY SERVICES MARKET, BY PHASE, 2020-2029 (USD MILLION)

TABLE 104 SWITZERLAND CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 105 SWITZERLAND CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 106 BELGIUM CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 107 BELGIUM IN VITRO CARDIAC SAFETY ASSESSMENT SERVICES IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 108 BELGIUM HUMAN IPSC-DERIVED CARDIOMYOCYTES MEA ASSAYS IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 109 BELGIUM COMPREHENSIVE IN VITRO PROARRHYTHMIA ASSAY (CIPA) IN CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 110 BELGIUM CARDIAC SAFETY SERVICES MARKET, BY PHASE, 2020-2029 (USD MILLION)

TABLE 111 BELGIUM CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 112 BELGIUM CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 113 REST OF EUROPE CARDIAC SAFETY SERVICES MARKET, BY SERVICES, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 EUROPE CARDIAC SAFETY SERVICES MARKET: SEGMENTATION

FIGURE 2 EUROPE CARDIAC SAFETY SERVICES MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE CARDIAC SAFETY SERVICES MARKET: DROC ANALYSIS

FIGURE 4 EUROPE CARDIAC SAFETY SERVICES MARKET: EUROPE VS COUNTRY MARKET ANALYSIS

FIGURE 5 EUROPE CARDIAC SAFETY SERVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE CARDIAC SAFETY SERVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE CARDIAC SAFETY SERVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE CARDIAC SAFETY SERVICES MARKET: MARKET END USER GRID

FIGURE 9 EUROPE CARDIAC SAFETY SERVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE CARDIAC SAFETY SERVICES MARKET: SEGMENTATION

FIGURE 11 THE INCREASE IN DEMAND FOR CARDIAC SAFETY SERVICES ARE EXPECTED TO DRIVE THE EUROPE CARDIAC SAFETY SERVICES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 ECG/HOLTER MEASUREMENTS SUBSTITUTE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CARDIAC SAFETY SERVICES MARKET IN 2022 & 2029

FIGURE 13 PATIENT FLOW DIAGRAM FOR ANY RANDOM DRUG

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE CARDIAC SAFETY SERVICES MARKET

FIGURE 15 EUROPE CARDIAC SAFETY SERVICES MARKET: BY SERVICES, 2021

FIGURE 16 EUROPE CARDIAC SAFETY SERVICES MARKET: BY SERVICES, 2022-2029 (USD MILLION)

FIGURE 17 EUROPE CARDIAC SAFETY SERVICES MARKET: BY SERVICES, CAGR (2022-2029)

FIGURE 18 EUROPE CARDIAC SAFETY SERVICES MARKET: BY SERVICES, LIFELINE CURVE

FIGURE 19 EUROPE CARDIAC SAFETY SERVICES MARKET: BY PHASE, 2021

FIGURE 20 EUROPE CARDIAC SAFETY SERVICES MARKET: BY PHASE, 2022-2029 (USD MILLION)

FIGURE 21 EUROPE CARDIAC SAFETY SERVICES MARKET: BY PHASE, CAGR (2022-2029)

FIGURE 22 EUROPE CARDIAC SAFETY SERVICES MARKET: BY PHASE, LIFELINE CURVE

FIGURE 23 EUROPE CARDIAC SAFETY SERVICES MARKET: BY TYPE, 2021

FIGURE 24 EUROPE CARDIAC SAFETY SERVICES MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 25 EUROPE CARDIAC SAFETY SERVICES MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 26 EUROPE CARDIAC SAFETY SERVICES MARKET: BY TYPE, LIFELINE CURVE

FIGURE 27 EUROPE CARDIAC SAFETY SERVICES MARKET: BY END USER, 2021

FIGURE 28 EUROPE CARDIAC SAFETY SERVICES MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 29 EUROPE CARDIAC SAFETY SERVICES MARKET: BY END USER, CAGR (2022-2029)

FIGURE 30 EUROPE CARDIAC SAFETY SERVICES MARKET: BY END USER, LIFELINE CURVE

FIGURE 31 EUROPE CARDIAC SAFETY SERVICES MARKET: SNAPSHOT (2021)

FIGURE 32 EUROPE CARDIAC SAFETY SERVICES MARKET: BY COUNTRY (2021)

FIGURE 33 EUROPE CARDIAC SAFETY SERVICES MARKET: BY COUNTRY (2022 & 2029)

FIGURE 34 EUROPE CARDIAC SAFETY SERVICES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 35 EUROPE CARDIAC SAFETY SERVICES MARKET: BY SERVICES (2022-2029)

FIGURE 36 EUROPE CARDIAC SAFETY SERVICES MARKET: COMPANY SHARE 2021 (%)

查看详细信息

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。